ActX

Using genetics to personalize medical care. ActX provides actionable clinical information based on your genetics to you and your healthcare provider.

[ActX @ActX]

A pharmacogenomics project done right can provide real world value for patients, providers, and help to differentiate a health system as a world-class leader.

Read our latest guide to discover key considerations and where to begin.

https://t.co/e2R1qXx93h

[ActX @ActX]

Sweden has surpassed half a million completed genomic analyses as part of the country's routine healthcare operations. The goal is simple: provide more accurate diagnoses and offer more precise treatment.

Learn more:
https://t.co/ONJPRFFVGt

[ActX @ActX]

AI tools are increasingly being utilized to build custom clinical applications - driven directly by physicians. The potential is massive, but there are several key considerations for healthcare IT leaders.

Learn more:
https://t.co/0FyVmGeCcs

[ActX @ActX]

A new study aims to help individuals suffering from severe mental health problems such as schizophrenia and bipolar disorder. Sponsored by England's NHS, the research could lead to a breakthrough in the understand of severe mental illness.

Learn more :
https://t.co/dDUp4B4zaG

[ActX @ActX]

A new study funded by the National Institutes of Health (NIH) hopes to explain why some people are more likely to develop diabetes. The results are promising, but are likely one piece of a more complex puzzle.

Learn more:
https://t.co/mTgJZqoKEm

[ActX @ActX]

Sweden has surpassed half a million completed genomic analyses as part of the country's routine healthcare operations. The goal is simple: provide more accurate diagnoses and offer more precise treatment.

Learn more:
https://t.co/ONJPRFFVGt

[ActX @ActX]

ActX is excited to announce we have entered into an agreement to provide dynamic genetic reporting for patients participating in the GUIDE program. GUIDE is a Medicare initiative to help dementia patients remain safely at home longer.

Learn more:
https://t.co/CvzllU1U0x

[ActX @ActX]

A new study has uncovered genetic factors linked to poor outcomes for lung cancer, affecting both smokers and non-smokers alike.

Researchers hope the study will pave the way toward better clinical care.

Learn more:
https://t.co/rkOLTwCUW9

[ActX @ActX]

@ActX makes genetics a core part of healthcare. With the My ActX Genomic Profile app you can share your genetic information quickly and easily with your healthcare provider.

The app is available for iOS and Android.

Learn more:
https://t.co/ni9gMQ6C54

[ActX @ActX]

Precision medicine continues to expand worldwide. Singapore recently launched the next phase of it's national program, enrolling up to 450,000 patients to build a genomic database and deliver care at scale.

Learn more:
https://t.co/FdZAj7C5cc

[ActX @ActX]

AI tools are increasingly being utilized to build custom clinical applications - driven directly by physicians. The potential is massive, but there are several key considerations for healthcare IT leaders.

Learn more:
https://t.co/0FyVmGeCcs

[ActX @ActX]

Preemptive pharmacogenomics for cardiovascular care has the potential to reduce costs and improve patient outcomes.

Learn more:
https://t.co/cgu4CP6WpF

[ActX @ActX]

@ActX makes genetics a core part of healthcare. With the My ActX Genomic Profile app you can share your genetic information quickly and easily with your healthcare provider.

The app is available for iOS and Android.

Learn more:
https://t.co/ni9gMQ6C54

[ActX @ActX]

A new study has uncovered genetic factors linked to poor outcomes for lung cancer, affecting both smokers and non-smokers alike.

Researchers hope the study will pave the way toward better clinical care.

Learn more:
https://t.co/rkOLTwCUW9

[ActX @ActX]

A new study aims to help individuals suffering from severe mental health problems such as schizophrenia and bipolar disorder. Sponsored by England's NHS, the research could lead to a breakthrough in the understand of severe mental illness.

Learn more :
https://t.co/LOM6qs0zge

[ActX @ActX]

Medicare is expanding in the U.S.

With the recent coverage expansion for the NGS region, all 50 states now have local coverage designations (LCD) for pharmacogenomics. This marks a significant moment for precision medicine nationwide.

Learn more:
https://t.co/zclYSGpNiO

[ActX @ActX]

A pair of coordinated international studies investigated the link between genomics and our gut microbiome. The results show genetics have a clear influence on which bacteria are present and their role.

Learn more:
https://t.co/wnurmvHiJ5

[ActX @ActX]

Scotland has become the first part of the UK to screen newborns for spinal muscular atrophy (SMA), a rare disease that can be drastically limit life expectancy. With early detection, treatments can provide significantly better outcomes.

Learn more:
https://t.co/YUzgcuEnct

[ActX @ActX]

@ActX makes genetics a core part of healthcare. With the My ActX Genomic Profile app you can share your genetic information quickly and easily with your healthcare provider.

The app is available for iOS and Android.

Learn more:
https://t.co/ni9gMQ6C54

[ActX @ActX]

Preemptive pharmacogenomics for cardiovascular care has the potential to reduce costs and improve patient outcomes.

Learn more:
https://t.co/cgu4CP6WpF

[ActX @ActX]

A new research program seeks to study people with harmful genetic mutations who never develop diseases doctors would expect them to.

The project hopes to learn from these patients and develop more effective drugs for rare genetic diseases.

Learn more:
https://t.co/rxqSpbG32r